QT
NAGE

Quantbot Technologies’s Niagen Bioscience NAGE Stock Holding History

Quantbot Technologies’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$90.2K Sell
28,265
-91,408
-76% -$371K ﹤0.01% 1489
2026
Q1 		$528K Buy
+119,673
New +$646K 0.02% 839
2025
Q4 		– Sell
-5,163
Closed -$48.2K – 2274
2025
Q3 		$48.2K Sell
5,163
-71,136
-93% -$718K ﹤0.01% 1529
2025
Q2 		$1.1M Buy
76,299
+49,363
+183% +$487K 0.03% 746
2025
Q1 		$186K Sell
26,936
-2,413
-8% -$15.2K 0.01% 1143
2024
Q4 		$156K Buy
+29,349
New +$161K 0.01% 1108
2022
Q1 		– Sell
-1,800
Closed -$6K – 2125
2021
Q4 		$6K Buy
1,800
+1,100
+157% +$5.94K ﹤0.01% 1366
2021
Q3 		$4K Sell
700
-253
-27% -$2.08K ﹤0.01% 1426
2021
Q2 		$9K Sell
953
-757
-44% -$6.6K ﹤0.01% 1323
2021
Q1 		$15K Buy
+1,710
New +$13.6K ﹤0.01% 1211
2018
Q1 		– Sell
-500
Closed -$2K – 1564
2017
Q4 		$2K Buy
+500
New +$2.7K ﹤0.01% 1148

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Quantbot Technologies's NAGE Position: Q2 2026 in Review

Quantbot Technologies reduced its Niagen Bioscience (NAGE) stake by 76% in Q2 2026, selling an estimated $371K and leaving 28,265 shares worth $90.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1489.

Quantbot Technologies first reported a position in NAGE in Q4 2017 and has held it in 11 quarters since. The position peaked at $1.1M in Q2 2025. 140 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

  • Quantbot Technologies held 28,265 shares of Niagen Bioscience worth $90.2K as of Q2 2026.
  • Quantbot Technologies sold 91,408 Niagen Bioscience shares in Q2 2026, an estimated $371K.
  • Niagen Bioscience made up ﹤0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1489 holding.
  • Quantbot Technologies first reported a position in Niagen Bioscience in Q4 2017 and has held it in 11 quarters since.
  • Quantbot Technologies's Niagen Bioscience position peaked at $1.1M in Q2 2025.
  • 140 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.